Financials
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
AGL Catalyst Timeline
Dated clinical, regulatory and corporate events for agilon health, inc.
Past FDA Catalysts and PDUFA Decisions
How AGL actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Drug Pipeline Intelligence
No drug pipeline
agilon health, inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every AGL program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Schwaneke Jeffrey A.Officer (Chief Financial Officer) | Disposition | -2,311 138,031 held | $111.74 | 07/01/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in AGL
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| Avidity Partners | 0.3 % | 1.32 M | 305.10 K |
Ownership Trends
AGL Short Interest
Shares sold short, counted twice a month.
Options Data
Option Volume
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-12-18 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
Competitive positioning
How AGL ranks across every disease it competes in
AGL News
agilon health to Host Virtual Investor Event “Driving Performance At Scale: The agilon Framework” on November 17, 2026
Agilon Health announced a virtual investor event scheduled for November 17, 2026. Key executives will discuss the company's clinical strategy, technology platform, and quality initiatives. The event aims to showcase the value delivered to physician partners and patients through the Total Care Model, followed by a live Q&A session.
Read more →agilon health Reports Third Quarter 2026 Results
Agilon Health reported a 6% revenue increase to $1.52 billion for Q3 2026. The company also achieved a net income of $35 million, a significant turnaround from a loss of $110 million in the same quarter last year. Adjusted EBITDA improved to $64 million, reflecting operational progress and effective payor contracting.
Read more →agilon health Sets Date to Report Third Quarter 2026 Financial Results
Agilon Health, Inc. announced it will release its financial results for the third quarter of 2026 after market close on November 4, 2026. A conference call will follow at 4:30 p.m. ET to discuss these results. The call will be accessible via phone and webcast, with a replay available afterward.
Read more →agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO
Agilon Health has expanded its partnership with The Jackson Clinic by integrating it into its Senior Health Connect Accountable Care Organizations (ACOs). This collaboration is expected to enhance healthcare delivery by leveraging The Jackson Clinic's extensive network of over 130 providers across various specialties. The partnership aims to empower physicians and improve patient outcomes in the community.
Read more →agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO
Agilon Health has announced an expansion of its partnership with Springfield Clinic, which will now join its Senior Health Connect Accountable Care Organizations (ACOs). This collaboration aims to enhance healthcare delivery and improve patient outcomes in the community. Springfield Clinic, with over 650 physicians, is well-positioned to contribute to this initiative.
Read more →agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO
Agilon Health has expanded its partnership with Family Practice Center in Pennsylvania, integrating the latter into its Senior Health Connect Accountable Care Organizations. This collaboration aims to enhance healthcare services for seniors, leveraging the strengths of Family Practice Center, which serves over 200,000 patients. The move reflects agilon's commitment to empowering physicians and improving community health.
Read more →agilon health Announces Revised Presentation Time at the 2026 Jefferies Healthcare Services and Technology Conference
Agilon Health announced a revised presentation time for its management team at the 2026 Jefferies Healthcare Services and Technology Conference. The fireside chat is scheduled for 4:00 PM ET on September 14, 2026. Investors can listen to the presentation via a webcast on the company's investor relations website.
Read more →agilon health to Participate in Upcoming Conferences
Agilon Health, Inc. (NYSE: AGL) announced its participation in several upcoming conferences, including the Wells Fargo 21st Annual Healthcare Conference and the Jefferies Healthcare Services and Technology Conference. The management team will engage in a fireside chat, with webcasts available for some events. Agilon aims to empower physicians and enhance healthcare delivery.
Read more →agilon health Reports Second Quarter 2026 Results
Agilon Health, Inc. reported strong second quarter results for 2026, surpassing expectations. The company also raised its full-year guidance for total revenues, medical margin, and Adjusted EBITDA. This performance highlights the effectiveness of Agilon's strategic initiatives and boosts confidence in future growth.
Read more →agilon health Reports ACO REACH Model Results for 2024 Performance Year
Agilon Health reported significant financial results for its ACOs under the ACO REACH model for the 2024 performance year. The company achieved $229 million in gross savings, translating to a 13.6% savings rate, with $54 million benefiting the Medicare Trust Fund. This performance highlights the effectiveness of agilon's approach in managing healthcare costs.
Read more →agilon health Sets Date to Report Second Quarter 2026 Financial Results
Agilon Health has announced the date for its second quarter 2026 financial results report. The specific details regarding the report's content or any anticipated highlights were not provided in the announcement.
Read more →agilon health Reports First Quarter 2026 Results
Agilon Health has reported its financial results for the first quarter of 2026. The article provides limited details regarding the performance metrics or any significant developments during this period. Further insights into the company's operations or future outlook are not provided.
Read more →agilon health Reports First Quarter 2026 Results Raises Full-Year 2026 Total Revenues, Medical Margin and Adjusted EBITDA Guidance
Agilon Health reported its first-quarter results for 2026, showcasing a 162% increase in Adjusted EBITDA and positive short-term guidance for total revenues and medical margins. The company saw some challenges, including an 11% drop in total members, impacted by strategic market exits. Leadership changes, including the appointment of a new CEO, signal a focus on operational enhancement. Despite a decrease in year-over-year revenue, the firm expressed confidence in its long-term growth trajectory.
Read more →agilon health Appoints Tim O’Rourke as Chief Executive Officer
Agilon Health has appointed Tim O’Rourke as the new Chief Executive Officer. This leadership change is expected to impact the company's strategic direction. Further details about O'Rourke's background and plans for the company have not been disclosed in the article.
Read more →agilon health Appoints Tim O'Rourke as Chief Executive Officer Healthcare industry veteran with more than 25 years of payor, provider and value-based care leadership to lead agilon's next chapter
Agilon Health has announced the appointment of Tim O'Rourke as its new Chief Executive Officer, effective May 7, 2026, following a comprehensive search. O'Rourke succeeds Ronald A. Williams, who will remain as Chairman of the Board. With over 25 years in healthcare leadership, O'Rourke aims to build on agilon's recent operational and financial improvements, focusing on delivering value-based care. He expresses confidence in supporting the company's physician partners to achieve sustainable health care outcomes.
Read more →agilon health Sets Date to Report First Quarter 2026 Financial Results
Agilon Health has announced the date for reporting its financial results for the first quarter of 2026. The specific date has not been detailed in the article. This announcement is part of the company's regular financial reporting schedule.
Read more →agilon health Announces Reverse Stock Split
Agilon Health, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-25, effective March 30, 2026. This decision follows the approval by stockholders at a special meeting and is aimed at increasing the stock price above $1.00 to comply with NYSE requirements. The split is expected to enhance marketability and attract a broader range of investors, while the company's stock will trade on a split-adjusted basis beginning March 31, 2026.
Read more →agilon health Reports Fourth Quarter and Full Year Fiscal 2025 Results Issues 2026 Guidance Highlighting Expected Breakeven Adjusted EBITDA Midpoint
Agilon Health has released its fourth quarter and full year results for fiscal 2025, indicating both challenges and expectations for future improvement. The company experienced a slight revenue increase in Q4 2025, but overall annual revenue declined compared to the previous year. Significant losses were reported, with a net loss that nearly doubled year-over-year, although there is optimism regarding a possible recovery in 2026. Agilon's guidance includes expectations for breakeven Adjusted EBITDA, reflecting strategic transformation efforts underway.
Read more →